KALV - KalVista Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Oct 2019)Next Qtr. (Jan 2020)Current Year (2020)Next Year (2021)
No. of Analysts7777
Avg. Estimate-0.55-0.11-1.25-1.95
Low Estimate-0.63-0.67-2.52-3.79
High Estimate-0.381.491.173.35
Year Ago EPS-0.22-0.23-1.38-1.25
Revenue EstimateCurrent Qtr. (Oct 2019)Next Qtr. (Jan 2020)Current Year (2020)Next Year (2021)
No. of Analysts7777
Avg. Estimate3.26M12.86M30.99M26.92M
Low Estimate3M3M12.4MN/A
High Estimate3.7M43.1M73.1M140.1M
Year Ago SalesN/AN/A16.13M30.99M
Sales Growth (year/est)N/AN/A92.20%-13.10%
Earnings History10/30/20181/30/20194/29/20197/30/2019
EPS Est.-0.46-0.45-0.42-0.62
EPS Actual-0.22-0.23-0.49-0.42
Difference0.240.22-0.070.2
Surprise %52.20%48.90%-16.70%32.30%
EPS TrendCurrent Qtr. (Oct 2019)Next Qtr. (Jan 2020)Current Year (2020)Next Year (2021)
Current Estimate-0.55-0.11-1.25-1.95
7 Days Ago-0.55-0.04-1.11-2.05
30 Days Ago-0.55-0.04-1.11-2.05
60 Days Ago-0.650.48-1.8-2.18
90 Days Ago-0.620.81-1.52-2.01
EPS RevisionsCurrent Qtr. (Oct 2019)Next Qtr. (Jan 2020)Current Year (2020)Next Year (2021)
Up Last 7 Days1111
Up Last 30 Days1111
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesKALVIndustrySectorS&P 500
Current Qtr.-150.00%N/AN/A-0.02
Next Qtr.52.20%N/AN/A0.06
Current Year9.40%N/AN/A-0.02
Next Year-56.00%N/AN/A0.14
Next 5 Years (per annum)N/AN/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A